Physician profile
Ivy Salom
NPI 1952593170
$593.33
in general payments reported to CMS, 2019-2025
8 companies · $33.86 in 2025
The $33.86 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.77 · 2020: $16.29 · 2022: $33.61 · 2023: $302 · 2024: $160 · 2025: $33.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Travel and Lodging: $3.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $492.66 |
| Travel and Lodging | $3.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $167.97 | 2023 | |
| Hologic Sales and Service, LLC | $159.54 | 2024 | Trident Specimen Radiography System |
| Elucent Medical | $134.29 | 2023 | |
| Amgen INC. | $35.11 | 2019 | |
| Abbvie INC. | $33.86 | 2025 | |
| Integra Lifesciences Corporation | $33.61 | 2022 | |
| Merck Sharp & Dohme LLC | $16.29 | 2020 | |
| Eusa Pharma (US) LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ivy Salom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.